Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devane

Showing results (141-150 of 987) with videos related to

Pageof 99
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 21, 2003
Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitroJun-Sheng Wang, C Lindsay DeVane
ANZ Journal of Surgery|September 22, 2005
Complications and outcomes of single-stage bilateral total knee arthroplastyGeoffrey Horne, Peter Devane, Kathryn Adams
Fertility and Sterility|December 1, 1986
Bromocriptine therapy in normoprolactinemic women with unexplained infertility and galactorrheaG W DeVane, D S Guzick
Pharmacotherapy|September 19, 2023
Standards of practice to advance the quality of health careC Lindsay DeVane, Jerry L Bauman
Nursing Leadership (Toronto, Ont.)|October 26, 2021
Coastal Mental Health and Substance Use Services' COVID-19 Response: A Quality Improvement InitiativeCourtney Devane, Luc Saulnier, Linda Latham
Psychopharmacology Bulletin|October 26, 2002
Psychoactive drug interactions with pharmacotherapy for diabetesC Lindsay DeVane, John S Markowitz
Psychopharmacology Bulletin|October 26, 2002
The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum)J S Markowitz, C L DeVane
Therapeutic Drug Monitoring|January 1, 1985
Stability of bupropion and its major metabolites in human plasmaS C Laizure, C L DeVane
Journal of Clinical Psychopharmacology|February 1, 2000
Rifampin-induced selective serotonin reuptake inhibitor withdrawal syndrome in a patient treated with sertralineJ S Markowitz, C L DeVane
Bulletin of the Menninger Clinic|March 1, 2000
Avoiding psychotropic drug interactions in the cardiovascular patientC L DeVane, J S Markowitz
Pageof 99

Showing results (141-150 of 987) with videos related to

Sort By:
Pageof 99
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 21, 2003
Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitroJun-Sheng Wang, C Lindsay DeVane
ANZ Journal of Surgery|September 22, 2005
Complications and outcomes of single-stage bilateral total knee arthroplastyGeoffrey Horne, Peter Devane, Kathryn Adams
Fertility and Sterility|December 1, 1986
Bromocriptine therapy in normoprolactinemic women with unexplained infertility and galactorrheaG W DeVane, D S Guzick
Pharmacotherapy|September 19, 2023
Standards of practice to advance the quality of health careC Lindsay DeVane, Jerry L Bauman
Nursing Leadership (Toronto, Ont.)|October 26, 2021
Coastal Mental Health and Substance Use Services' COVID-19 Response: A Quality Improvement InitiativeCourtney Devane, Luc Saulnier, Linda Latham
Psychopharmacology Bulletin|October 26, 2002
Psychoactive drug interactions with pharmacotherapy for diabetesC Lindsay DeVane, John S Markowitz
Psychopharmacology Bulletin|October 26, 2002
The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum)J S Markowitz, C L DeVane
Therapeutic Drug Monitoring|January 1, 1985
Stability of bupropion and its major metabolites in human plasmaS C Laizure, C L DeVane
Journal of Clinical Psychopharmacology|February 1, 2000
Rifampin-induced selective serotonin reuptake inhibitor withdrawal syndrome in a patient treated with sertralineJ S Markowitz, C L DeVane
Bulletin of the Menninger Clinic|March 1, 2000
Avoiding psychotropic drug interactions in the cardiovascular patientC L DeVane, J S Markowitz
Pageof 99